Skip to main content
. 2012 Jul 30;7(7):e41076. doi: 10.1371/journal.pone.0041076

Figure 4. Inhibition of p38 MAPK blocks the effects of estrogen receptor-α stimulation on cardiac myofilament activation.

Figure 4

Hearts were perfused with an inhibitor of p38 MAPK (SB203580, 1 µM) 5 min prior to and during perfusion with 100 nM PPT. A. 1 min PPT. B. 2.5 min PPT. C. 5 min PPT. Inhibition of p38 MAPK blocked the effects of PPT on actomyosin MgATPase activity at all time points. D. Treatment with SB203580 had no effect on myofilament activation at all timepoints. N = 5 for all groups.